SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Navarro Estrada Jose L.) srt2:(2019)"

Search: WFRF:(Navarro Estrada Jose L.) > (2019)

  • Result 1-2 of 2
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Bernal, Ximena E., et al. (author)
  • Empowering Latina scientists
  • 2019
  • In: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 363:6429, s. 825-826
  • Journal article (other academic/artistic)
  •  
2.
  • Hohnloser, Stefan H., et al. (author)
  • Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
  • 2019
  • In: JACC. - : ELSEVIER SCIENCE INC. - 1936-8798 .- 1876-7605. ; 12:16, s. 1553-1561
  • Journal article (peer-reviewed)abstract
    • OBJECTIVES: The study sought to evaluate the effect of dabigatran dual therapy versus warfarin triple therapy across categories of renal function in the RE-DUAL PCI (Randomized Evaluation of Dual Antithrombotic Therapy with Dabigatran versus Triple Therapy with Warfarin in Patients with Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) trial.BACKGROUND: The RE-DUAL PCI (NCT02164864) trial of patients with atrial fibrillation undergoing percutaneous coronary intervention reported that dabigatran dual therapy (110 or 150 mg twice daily, plus clopidogrel or ticagrelor) reduced the primary endpoint of major bleeding events (MBE) or clinically relevant nonmajor bleeding events (CRNMBE) compared with warfarin triple therapy, with noninferiority in overall thromboembolic events.METHODS: Risk of a first MBE or CRNMBE and the composite of death or thromboembolic event (DTE) or unplanned revascularization were evaluated in 2,725 patients according to baseline creatinine clearance (CrCl) categories: 30 to <50, 50 to <80, and >= 80 ml/min.RESULTS: Compared with warfarin, dabigatran 110 mg dual therapy reduced risk of MBE or CRNMBE across all categories of CrCl (p for interaction = 0.19). Dabigatran 150 mg dual therapy reduced risk of MBE or CRNMBE regardless of the CrCl category (p for interaction = 0.31). Risk of DTE or unplanned revascularization was similar to warfarin triple therapy for dabigatran 110 mg dual therapy across all CrCl categories. Dabigatran 150 mg dual therapy versus warfarin triple therapy had similar risk for DTE or unplanned revascularization in patients with CrCl 30 to <80 ml/min and lower risk at CrCl >= 80 ml/min (p for interaction = 0.02).CONCLUSIONS: In the RE-DUAL PCI trial, dabigatran dual therapy reduced bleeding events versus warfarin triple therapy irrespective of renal function, with overall similar risks of thromboembolic events but lower risks with dabigatran 150 mg in patients with normal CrCl. 
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-2 of 2
Type of publication
journal article (2)
Type of content
other academic/artistic (1)
peer-reviewed (1)
Author/Editor
Bhatt, Deepak L (1)
Hohnloser, Stefan H (1)
Steg, Philippe Gabri ... (1)
Oldgren, Jonas, 1964 ... (1)
Ten Berg, Jurrien M (1)
Cannon, Christopher ... (1)
show more...
Lip, Gregory Y H (1)
Castaneda-Gomez, Lau ... (1)
Guedes, Thais (1)
Zapata, Felipe (1)
Orizaola, German (1)
Dick, Christopher W. (1)
Pimiento, Catalina (1)
Ortiz-Barrientos, Da ... (1)
Bernal, Ximena E. (1)
Rojas, Bibiana (1)
Pinto-E, Maria Aleja ... (1)
Mendoza-Henao, Angel ... (1)
Herrera-Montes, Adri ... (1)
Isabel Herrera-Monte ... (1)
Caceres Franco, Andr ... (1)
Ceron-Souza, Ivania (1)
Paz, Andrea (1)
Vergara, Daniela (1)
Barragan Contreras, ... (1)
Salazar, Camilo (1)
Bohorquez Alonso, Ma ... (1)
Sanchez, Adriana (1)
Olaya-Castro, Alexan ... (1)
Urbina-Cardona, Nico ... (1)
Guayasamin, Juan M. (1)
Uy, Floria Mora-Kepf ... (1)
Feris, Faride Lamadr ... (1)
Franco-Orozco, Barba ... (1)
Munoz, Martha M. (1)
Patricia Rincon-Diaz ... (1)
Sanchez Herrera, Mel ... (1)
Betancourth-Cundar, ... (1)
Tarvin, Rebecca D. (1)
Marquez, Roberto (1)
Lopez-Aguirre, Camil ... (1)
Ron, Santiago R. (1)
Ramirez, Santiago (1)
Paez-Vacas, Monica (1)
Gaitan-Espitia, Juan ... (1)
Vianna, Juliana A. (1)
Varela-Jaramillo, An ... (1)
Sanchez-Martinez, Pa ... (1)
Caminer Rodriguez, M ... (1)
Garcia-Robledo, Carl ... (1)
show less...
University
Uppsala University (1)
Chalmers University of Technology (1)
Language
English (2)
Research subject (UKÄ/SCB)
Medical and Health Sciences (2)
Natural sciences (1)
Year
2019 (2)Undo refine

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view